These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 22749740)
1. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). Soleymani Fard S; Jeddi Tehrani M; Ardekani AM Prostaglandins Leukot Essent Fatty Acids; 2012 Jul; 87(1):17-24. PubMed ID: 22749740 [TBL] [Abstract][Full Text] [Related]
2. Bryostatin-1, Fenretinide and 1α,25 (OH)(2)D(3) Induce Growth Inhibition, Apoptosis and Differentiation in T and B Cell-Derived Acute Lymphoblastic Leukemia Cell Lines (CCRF-CEM and Nalm-6). Ardekani AM; Fard SS; Jeddi-Tehrani M; Ghahremanzade R Avicenna J Med Biotechnol; 2011 Oct; 3(4):177-93. PubMed ID: 23407583 [TBL] [Abstract][Full Text] [Related]
3. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells. Zhang X; Huang H; Xu Z; Zhan R Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853 [TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells. Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477 [TBL] [Abstract][Full Text] [Related]
5. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257 [TBL] [Abstract][Full Text] [Related]
6. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis. Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205 [TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells. Shao N; Ma D; Wang J; Lu T; Guo Y; Ji C Ann Hematol; 2013 Jan; 92(1):33-9. PubMed ID: 22968660 [TBL] [Abstract][Full Text] [Related]
8. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine. Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and apoptotic effects of prenylflavonoid artonin B in human acute lymphoblastic leukemia cells. Lee CC; Lin CN; Jow GM Acta Pharmacol Sin; 2006 Sep; 27(9):1165-74. PubMed ID: 16923337 [TBL] [Abstract][Full Text] [Related]
10. A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell lines. Altenburg JD; Harvey KA; McCray S; Xu Z; Siddiqui RA Biochem Biophys Res Commun; 2011 Jul; 411(2):427-32. PubMed ID: 21749860 [TBL] [Abstract][Full Text] [Related]
11. Plant-derived abrin-a induces apoptosis in cultured leukemic cell lines by different mechanisms. Ohba H; Moriwaki S; Bakalova R; Yasuda S; Yamasaki N Toxicol Appl Pharmacol; 2004 Mar; 195(2):182-93. PubMed ID: 14998684 [TBL] [Abstract][Full Text] [Related]
12. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. Romanski A; Bacic B; Bug G; Pfeifer H; Gul H; Remiszewski S; Hoelzer D; Atadja P; Ruthardt M; Ottmann OG Haematologica; 2004 Apr; 89(4):419-26. PubMed ID: 15075075 [TBL] [Abstract][Full Text] [Related]
13. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia. Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803 [TBL] [Abstract][Full Text] [Related]
14. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells. Abdelwahab SI; Abdul AB; Mohan S; Taha MM; Syam S; Ibrahim MY; Mariod AA Leuk Res; 2011 Feb; 35(2):268-71. PubMed ID: 20708800 [TBL] [Abstract][Full Text] [Related]
15. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma. Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864 [TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997 [TBL] [Abstract][Full Text] [Related]
17. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative. Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129 [TBL] [Abstract][Full Text] [Related]